Associated Banc-Corp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.2M Sell
43,160
-311
-0.7% -$169K 0.56% 55
2025
Q4
$25.2M Buy
43,471
+24
+0.1% +$13.6K 0.64% 38
2025
Q3
$21.1M Sell
43,447
-968
-2% -$451K 0.55% 49
2025
Q2
$18M Sell
44,415
-862
-2% -$360K 0.51% 54
2025
Q1
$22.5M Sell
45,277
-597
-1% -$323K 0.69% 43
2024
Q4
$23.9M Sell
45,874
-23,111
-34% -$12.7M 0.72% 39
2024
Q3
$42.7M Sell
68,985
-73
-0.1% -$43.2K 1.25% 19
2024
Q2
$38.2M Buy
69,058
+283
+0.4% +$162K 1.19% 19
2024
Q1
$40M Buy
68,775
+452
+0.7% +$254K 1.27% 18
2023
Q4
$36.3M Buy
68,323
+101
+0.1% +$48.9K 1.26% 17
2023
Q3
$34.5M Buy
68,222
+646
+1% +$344K 1.34% 18
2023
Q2
$35.3M Buy
67,576
+557
+0.8% +$301K 1.33% 16
2023
Q1
$38.6M Sell
67,019
-461
-0.7% -$260K 1.55% 13
2022
Q4
$37.2M Buy
67,480
+316
+0.5% +$167K 1.55% 12
2022
Q3
$34.1M Sell
67,164
-351
-0.5% -$196K 1.57% 12
2022
Q2
$36.7M Buy
67,515
+1,001
+2% +$551K 1.61% 12
2022
Q1
$39.3M Buy
66,514
+1,134
+2% +$651K 1.51% 9
2021
Q4
$43.6M Buy
65,380
+985
+2% +$615K 1.6% 10
2021
Q3
$36.8M Buy
64,395
+1,783
+3% +$979K 1.45% 12
2021
Q2
$31.6M Buy
62,612
+21,063
+51% +$9.94M 1.25% 19
2021
Q1
$11.8M Sell
41,549
-13,440
-24% -$6.41M 0.73% 47
2020
Q4
$25.6M Sell
54,989
-3,988
-7% -$1.87M 1% 30
2020
Q3
$26M Buy
58,977
+16,329
+38% +$6.75M 1.12% 26
2020
Q2
$15.5M Buy
42,648
+1,089
+3% +$365K 0.7% 47
2020
Q1
$11.8M Sell
41,559
-1,930
-4% -$609K 0.63% 50
2019
Q4
$14.1M Buy
43,489
+145
+0.3% +$44K 0.7% 46
2019
Q3
$12.6M Buy
43,344
+797
+2% +$228K 0.68% 46
2019
Q2
$12.5M Buy
42,547
+2,173
+5% +$599K 0.69% 48
2019
Q1
$11.1M Buy
40,374
+1,581
+4% +$393K 0.64% 51
2018
Q4
$8.68M Buy
38,793
+3,176
+9% +$745K 0.57% 56
2018
Q3
$8.69M Buy
35,617
+4,237
+14% +$975K 0.48% 66
2018
Q2
$6.5M Buy
31,380
+3,029
+11% +$643K 0.38% 74
2018
Q1
$5.85M Buy
28,351
+4,119
+17% +$865K 0.33% 80
2017
Q4
$4.6M Sell
24,232
-408
-2% -$78.2K 0.25% 97
2017
Q3
$4.66M Buy
24,640
+14
+0.1% +$2.54K 0.26% 95
2017
Q2
$4.3M Sell
24,626
-667
-3% -$112K 0.24% 94
2017
Q1
$3.88M Sell
25,293
-147
-0.6% -$22.5K 0.23% 98
2016
Q4
$3.59M Sell
25,440
-257
-1% -$37.9K 0.22% 101
2016
Q3
$4.09M Sell
25,697
-292
-1% -$45K 0.26% 96
2016
Q2
$3.84M Sell
25,989
-755
-3% -$111K 0.25% 95
2016
Q1
$3.79M Buy
26,744
+779
+3% +$104K 0.25% 95
2015
Q4
$3.68M Sell
25,965
-1,361
-5% -$182K 0.24% 97
2015
Q3
$3.34M Buy
27,326
+191
+0.7% +$24.9K 0.23% 103
2015
Q2
$3.52M Sell
27,135
-253
-0.9% -$33K 0.23% 104
2015
Q1
$3.68M Sell
27,388
-349
-1% -$45K 0.23% 106
2014
Q4
$3.48M Buy
27,737
+879
+3% +$107K 0.22% 108
2014
Q3
$3.27M Buy
26,858
+306
+1% +$37.2K 0.21% 110
2014
Q2
$3.13M Buy
26,552
+135
+0.5% +$15.9K 0.2% 113
2014
Q1
$3.18M Buy
26,417
+992
+4% +$118K 0.22% 105
2013
Q4
$2.83M Buy
25,425
+300
+1% +$29.8K 0.2% 111
2013
Q3
$2.31M Buy
25,125
+602
+2% +$54.4K 0.18% 117
2013
Q2
$2.08M Buy
+24,523
New +$2.04M 0.17% 117

Other funds holding TMO

Associated Banc-Corp's TMO Position: Q1 2026 in Review

Associated Banc-Corp reduced its Thermo Fisher Scientific (TMO) stake by 0.72% in Q1 2026, selling an estimated $169K and leaving 43,160 shares worth $21.2M. The position accounts for 0.56% of the portfolio, ranked #55.

Associated Banc-Corp first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.6M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Associated Banc-Corp held 43,160 shares of Thermo Fisher Scientific worth $21.2M as of Q1 2026.
  • Associated Banc-Corp sold 311 Thermo Fisher Scientific shares in Q1 2026, an estimated $169K.
  • Thermo Fisher Scientific made up 0.56% of Associated Banc-Corp's portfolio in Q1 2026, its #55 holding.
  • Associated Banc-Corp first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Associated Banc-Corp's Thermo Fisher Scientific position peaked at $43.6M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.